Seroatlas · Human Serome Atlas

ACBD5

Acyl-CoA-binding domain-containing protein 5

Also known as: ACBD5_HUMAN, DKFZp434A2417, KIAA1996

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q5T8D3
Gene
ACBD5
Ensembl
ENSG00000107897
Chromosome
10
Canonical length
534 aa
Protein class
Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Peroxisomes

OverviewNCBI Gene

This gene encodes a member of the acyl-Coenzyme A binding protein family, known to function in the transport and distribution of long chain acyl-Coenzyme A in cells. This gene may play a role in the differentiation of megakaryocytes and formation of platelets. A related protein in yeast is involved in autophagy of peroxisomes. A mutation in this gene has been associated with autosomal dominant thrombocytopenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Canonical amino-acid sequenceUniProt

534 residues, UniProt reviewed canonical sequence.

>Q5T8D3|ACBD5
     1  MFQFHAGSWE SWCCCCLIPA DRPWDRGQHW QLEMADTRSV HETRFEAAVK VIQSLPKNGS
    61  FQPTNEMMLK FYSFYKQATE GPCKLSRPGF WDPIGRYKWD AWSSLGDMTK EEAMIAYVEE
   121  MKKIIETMPM TEKVEELLRV IGPFYEIVED KKSGRSSDIT SVRLEKISKC LEDLGNVLTS
   181  TPNAKTVNGK AESSDSGAES EEEEAQEEVK GAEQSDNDKK MMKKSADHKN LEVIVTNGYD
   241  KDGFVQDIQN DIHASSSLNG RSTEEVKPID ENLGQTGKSA VCIHQDINDD HVEDVTGIQH
   301  LTSDSDSEVY CDSMEQFGQE ESLDSFTSNN GPFQYYLGGH SSQPMENSGF REDIQVPPGN
   361  GNIGNMQVVA VEGKGEVKHG GEDGRNNSGA PHREKRGGET DEFSNVRRGR GHRMQHLSEG
   421  TKGRQVGSGG DGERWGSDRG SRGSLNEQIA LVLMRLQEDM QNVLQRLQKL ETLTALQAKS
   481  STSTLQTAPQ PTSQRPSWWP FEMSPGVLTF AIIWPFIAQW LVYLYYQRRR RKLN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ACBD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.59
Highest tissue expression
69 nTPM

Expression across tissuesHPA

Tissue

  • liver: 69 nTPM
  • spinal cord: 39 nTPM
  • heart muscle: 38 nTPM
  • duodenum: 38 nTPM
  • small intestine: 37 nTPM
  • kidney: 35 nTPM

Single-cell type

  • retinal pigment epithelial cells: 188 nCPM
  • epicardial cells: 175 nCPM
  • cardiomyocytes: 119 nCPM
  • hepatocytes: 90 nCPM
  • enterocytes: 77 nCPM
  • cone photoreceptor cells: 77 nCPM

Immune cell

  • gdT-cell: 15 nTPM
  • MAIT T-cell: 15 nTPM
  • non-classical monocyte: 15 nTPM
  • classical monocyte: 13 nTPM
  • myeloid DC: 13 nTPM
  • intermediate monocyte: 13 nTPM

Brain region

  • medulla oblongata: 66 nTPM
  • white matter: 66 nTPM
  • spinal cord: 65 nTPM
  • thalamus: 64 nTPM
  • basal ganglia: 64 nTPM
  • cerebellum: 63 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ACBD5.

Disease | AllUniProt

Conditions ACBD5 is implicated in, by any mechanism.

Disease | GeneticClinVar

24 pathogenic / likely-pathogenic of 446 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.53
gnomAD pLI
0.01
gnomAD missense Z
0.87
DepMap mean gene effect
0.06
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ACBD5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ACBD5 as an antibody target. Whether an autoantibody or antibody against ACBD5 could matter depends on whether native ACBD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ACBD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ACBD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ACBD5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...